SCHEMBL18319013

SCHEMBL18319013

Cc1cc(OC2CCN(C(=O)O)CC2)ccc1-c1cnc2ccccc2c1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 5/20 0.44
PIK3CD O00329 1/20 0.44
PRKCZ Q05513 1/20 0.44
IKBKB O14920 1/20 0.41
CHUK O15111 1/20 0.41
AKR1C3 P42330 2/20 0.41
AKR1C2 P52895 2/20 0.41
PARP10 Q53GL7 1/20 0.41
PARP11 Q9NR21 1/20 0.41
EGFR P00533 3/20 0.40
FGFR2 P21802 3/20 0.40
MTOR P42345 3/20 0.40
AKT1 P31749 2/20 0.40
SRC P12931 1/20 0.40
KCNH2 Q12809 1/20 0.40
EPHX1 P07099 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18318978 0.90 PIK3CA (0.48) PIK3CAPIK3CDPRKCZPARP10PARP11
SCHEMBL30497923 0.90 PIK3CA (0.48) PIK3CAPIK3CDPRKCZPARP10PARP11
SCHEMBL18318075 0.90 PIK3CA (0.54) PIK3CAPIK3CDPRKCZMTORAKT1
SCHEMBL18318162 0.90 PIK3CA (0.47) PIK3CAPIK3CDPRKCZAKR1C3AKR1C2
SCHEMBL18322881 0.81 PRKCZ (0.42) PIK3CAPIK3CDPRKCZPARP10PARP11
SCHEMBL18318408 0.81 AVPR2 (0.47) PIK3CAPIK3CDPRKCZ
SCHEMBL18318701 0.80 AKR1C3 (0.52) PIK3CAPIK3CDPRKCZAKR1C3AKR1C2
SCHEMBL18319024 0.80 FASN (0.49) PIK3CAPIK3CDPRKCZAKR1C3AKR1C2
SCHEMBL18318090 0.80 PIK3CD (0.44) PIK3CAPIK3CDPRKCZEGFRFGFR2
SCHEMBL18318137 0.79 PIK3CA (0.53) PIK3CAPIK3CDPRKCZAKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3310441-B1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES 89BIO LTD (IL) 2020-07-29 EP claimed
US-20230391723-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2023-12-07 US disclosed
US-11702388-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2023-07-18 US disclosed
US-20210230116-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2021-07-29 US disclosed
US-10851057-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2020-12-01 US disclosed
EP-3310441-B1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES 89BIO LTD (IL) 2020-07-29 EP disclosed
US-20190152913-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON LLC 2019-05-23 US disclosed
US-10221135-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2019-03-05 US disclosed
US-20180179159-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON LLC 2018-06-28 US disclosed
US-9902696-B2 1,4-substituted piperidine derivatives CEPHALON, INC. (US) 2018-02-27 US disclosed
US-20160368874-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON LLC 2016-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152913-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES FASN, CES1, CPT1A PIK3CA 752/4885PIK3CD 990/4885PRKCZ 2305/4885
US-20230391723-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A PIK3CA 752/4885PIK3CD 990/4885PRKCZ 2305/4885
US-20160368874-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES FASN, CES1, CPT1A PIK3CA 752/4885PIK3CD 990/4885PRKCZ 2305/4885
US-20210230116-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A PIK3CA 752/4885PIK3CD 990/4885PRKCZ 2305/4885
US-10221135-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A PIK3CA 752/4885PIK3CD 990/4885PRKCZ 2305/4885
US-11702388-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A PIK3CA 752/4885PIK3CD 990/4885PRKCZ 2305/4885
US-10851057-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A PIK3CA 752/4885PIK3CD 990/4885PRKCZ 2305/4885
US-20180179159-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES FASN, CES1, CPT1A PIK3CA 776/4885PIK3CD 1008/4885PRKCZ 2054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.